Developing new cancer treatment tools, using imaging techniques such as PET-CT and MRI, and new radiopharmaceuticals for next-generation personalized therapies (“Theranostics”) to target cancer first at the “diagnosis” phase and then at the “therapy” phase, using the same biological targets (“see to treat”).
Updated: NJ court says drugmakers can coordinate their legal fight against the government’s price negotiations
Four major drugmakers suing against the Inflation Reduction Act will have their arguments heard together in court next month as part of a strategy legal
February 21, 2024